HEALIUS LIMITED — Director's Dealing 2022

Nov 10, 2022

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

ntroduced 30/09/01 Amended 01/01/11
Name of entity	HEALIUS LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	John Mattick
Date of last notice	19 September 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	As shown
Date of change	11 November 2022
No. of securities held prior to change	27,542 Ordinary Shares J & L Mattick Retirement Fund
Class	NED Share Rights
Number acquired	15,093
Number disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$50,000 cash equivalent using the volume weighted average price of Ordinary Shares over the five business days immediately following the Healius Limited Annual General Meeting on 20 October 2022, being $3.3126.
No. of securities held after change	27,542 Ordinary Shares J & L Mattick Retirement Fund 15,093 NED Share Rights John Mattick

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under Issue of Securities under the NED Share Plan dividend reinvestment plan, participation in buyback

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written N/A clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?

Authorised by the Company Secretary.

Charles Tilley Company Secretary Date: 11 November 2022

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011